Caring for Alzheimer's

Posts Tagged ‘research’

Professor Solomon Diamond discusses how his noninvasive head probe for neurovascular coupling assessment will make it possible to diagnose and track Alzheimer’s disease.

Massachusetts couple Ralph and Leslie Hergert speak out about their experience with Alzheimer’s disease, the services of the Alzheimer’s Association, and their hope for the future. Thanks to Ralph, Leslie and Jesse Hergert, Dr. Olivia Okereke, and all who made this video possible. Produced by WeBo Media LLC for the Alzheimer’s Association, MA/NH Chapter.

AIDS, ALZHEIMER’S, PARKINSON’S & MULTIPLE SCLEROSIS BY BIOWARFARE RESEARCH UNDOING THE DAMAGE The body undoes the damage itself. The scarring in the brain of people with chronic fatigue and fibromyalgia will be repaired. There is cellular repair going on all the time. But the mycoplasma has moved on to the next cell. In the early stages of a disease, doxycycline may reverse the disease. It is one of the tetracycline antibiotics, but it is not bactericidal; it is bacteriostatic. It stops the growth of the mycoplasma, and if it is stopped long enough, then the immune system takes over. (Nicholson, GL, Doxycycline treatment and Desert Storm, JAMA, 1995, 273: 618-619), GULF WAR RESEARCH Professor Garth Nicholson, Ph.D., of the Institute for Molecular Medicine is one of the top experts on mycoplasma. He has been given an million grant to study 450 Gulf War veterans, because Gulf War illness is caused by the mycoplasma. Dr. Les Simpson has done most of the research in detecting the disease by the polymerase chain reaction blood test. You may contact Dr. Nicholson at 15162 Triton Lane, Huntington Beach, Ca, 92649-1401, tel 714-903-2900. In summary, there is a disease agent that is called a mycoplasma. All of these neurodegenerative systemic diseases are caused by a particle of a bacterial DNA, a mycoplasma, that enters into the cells of living organisms and takes the cells apart, sterol by sterol, leaving scar tissue, and causing all the range of symptoms that you see in …

It was believed that Alzheimer’s disease results when a particular protein randomly detaches itself from brain cells, which are usually connected, and to form tangles. It was thought this happened in many parts of the brain at the same time. But, new research is challenging this view. The latest research on the subject suggests the protein actually spreads cell by cell through the brain in a predictable way. The new findings are an important step in the battle against the disease. Al Jazeera’s Tarek Bazley reports.

Donate at: www.alzheimerbc.org

Need a big favour from y’all…… www.justgiving.com/benjiinsanitysilverstone

Case Western Reserve Researchers Discover FDA-approved Drug Rapidly Clears Amyloid from the Brain and Reverses Cognitive and Memory Defects. School of Medicine Neurosciences Gary Landreth, PhD Paige Cramer

Dr. Jan Lundberg, PH.D., executive VP science & technology and president Lilly research labs, shares his personal story first-hand about Alzheimers and underscores PhRMA (Pharmaceutical Research and Manufacturers of America)and Lilly’s sentiment that new treatments for this fatal disease are needed to help patients and their caregivers, as well as lessen the burden on the healthcare system.

Alzheimer’s researcher Dr. David Michelson of Merck & Co. tells us about several promising new approaches to a cure for Alzheimer’s disease.

January is Alzheimer’s Awareness month, and a walk will be held in Ottawa to raise money for research on the disease.